多参数MRI判定甲状腺相关眼病活动性的附加价值
结果显示平均Ve、平均ADC与平均SIR为活动性TAO的独立预测因子,三者联合的AUC为0.839,优于单独平均SIR的0.769(p=0.016)。结论认为DCE-MRI与DWI可为FS-T2WI分期提供附加价值。
要点
- 平均SIR、平均ADC、平均Ve均为活动性TAO的独立预测因子。
- 三者联合评估活动性优于单独使用FS-T2WI的平均SIR。
- DCE-MRI与DWI可提供眼外肌组织通透性及水分子扩散信息。
核心结论
- DCE-MRI与DWI可判定甲状腺相关眼病的疾病活动性,并为FS-T2WI分期提供附加价值。
研究设计与样本
- 治疗前对每例患者行DCE-MRI、DWI及FS-T2WI扫描,以眼外肌为测量对象。
- DCE-MRI采用基于模型分析获得Ktrans、Kep、Ve,DWI获得ADC,FS-T2WI获得信号强度比SIR。
关键影像表现/征象
- 活动性TAO患者的平均及最大Ve高于非活动性患者(p<0.05)。
- 活动性TAO患者的最低、平均及最大ADC高于非活动性患者(p<0.05)。
- 活动性TAO患者的最低、平均及最大SIR高于非活动性患者(p<0.05)。
诊断标准与关键数值
- 平均SIR(OR=3.449,p=0.002)、平均ADC(OR=1.008,p<0.001)和平均Ve(OR=14.138,p=0.022)是活动性TAO的独立预测因子。
- 平均Ve联合平均ADC及平均SIR的ROC曲线下面积为0.839。
- 单独平均SIR的ROC曲线下面积为0.769,联合模型与单独平均SIR比较p=0.016。
临床应用与阅片要点
- 日常报告TAO时可将FS-T2WI的SIR与DWI的ADC及DCE-MRI的Ve结合,判断疾病是否处于活动期。
- 评分时重点关注平均Ve、平均ADC和平均SIR三项指标,其联合应用优于仅依据FS-T2WI信号强度比。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To evaluate the performance of model-based dynamic contrast-enhanced (DCE)-MRI and diffusion-weighted imaging (DWI) in determining the disease activity of thyroid-associated ophthalmopathy (TAO), and to establish their additional value to fat-suppressed T2-weighted imaging (FS-T2WI) for staging TAO.
MATERIALS AND METHODS: Seventy-two patients with TAO (48 active, 96 eyes; 24 inactive, 48 eyes) were prospectively enrolled. DCE-MRI, DWI and FS-T2WI were scanned for pre-treatment evaluation. Simplified histogram parameters (min, mean, max) of DCE-MRI-derived Ktrans, Kep and Ve, apparent diffusion coefficient (ADC) and signal intensity ratio (SIR) on FS-T2WI of extraocular muscles were calculated for each orbit and compared between active and inactive groups. Multivariate analyses were used to identify independent indicators for disease activity. Receiver operating characteristic (ROC) curves analyses and DeLong tests were performed to evaluate and compare the performances of the identified significant imaging parameters and their combinations.
RESULTS: Active TAO patients showed significantly higher mean and maximum Ve, higher minimum, mean and maximum ADC, higher minimum, mean and maximum SIR than inactive patients (p < 0.05). Mean SIR (odds ratio (OR) = 3.449, p = 0.002), mean ADC (OR = 1.008, p < 0.001), and mean Ve (OR = 14.138, p = 0.022) were found to be independent predictors of active TAO. Combination of mean Ve, mean ADC and mean SIR outperformed mean SIR alone in staging TAO (area under ROC curves, 0.839 vs 0.769, p = 0.016).
CONCLUSION: DCE-MRI and DWI could determine the disease activity of TAO and provide additional value to FS-T2WI in staging TAO.
KEY POINTS: Question Fat-suppressed T2-weighted imaging was the most commonly used imaging technique for determining the disease activity of thyroid-associated ophthalmopathy; however, its performance needs to be improved. Findings Dynamic contrast-enhanced magnetic resonance imaging and diffusion-weighted imaging could provide added value to fat-suppressed T2-weighted imaging for determining the clinical activity of thyroid-associated ophthalmopathy. Clinical relevance Dynamic contrast-enhanced magnetic resonance imaging and diffusion-weighted imaging can provide information about tissue permeability and water molecule diffusion of extraocular muscles in patients with thyroid-associated ophthalmopathy (TAO), and therefore provide additional value to fat-suppressed T2-weighted imaging in staging TAO.
引用
- Pu, Wan, Chen, et al. Added value of multiparametric MRI combining dynamic contrast-enhanced and diffusion-weighted imaging for determining thyroid-associated ophthalmopathy activity. Eur Radiol. 2026. PMID: 41578080. doi:10.1007/s00330-025-12303-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。